{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:43:35Z","timestamp":1791333815448,"version":"4.3.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ebiom.2025.105728","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T23:14:20Z","timestamp":1745622860000},"page":"105728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-674X","authenticated-orcid":false,"given":"Caroline","family":"Struyfs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Van den Heede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Van Wesenbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Tully","family":"Waickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Rasschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Herrera-Taracena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-7682","authenticated-orcid":false,"given":"Stephen James","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnix","family":"Van Loock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-1313","authenticated-orcid":false,"given":"Ole","family":"Lagatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105728_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue infection","volume":"2","author":"Guzman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ebiom.2025.105728_bib3","series-title":"Dengue fact sheet","author":"Program WM","year":"2020"},{"key":"10.1016\/j.ebiom.2025.105728_bib4","series-title":"Dengue - global situation","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105728_bib6","series-title":"Situation report no 25 - dengue epidemiological situation in the region of the Americas - epidemiological week 25, 2024","year":"2024"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105728_bib8","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"issue":"7446","key":"10.1016\/j.ebiom.2025.105728_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105728_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40506-023-00263-w","article-title":"Dengue: update on clinically relevant therapeutic strategies and vaccines","volume":"15","author":"Palanichamy Kala","year":"2023","journal-title":"Curr Treat Options Infect Dis"},{"issue":"7953","key":"10.1016\/j.ebiom.2025.105728_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105728_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1473-3099(24)00030-6","article-title":"An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia","volume":"24","author":"Gunale","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"35","key":"10.1016\/j.ebiom.2025.105728_bib14","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.vaccine.2018.09.063","article-title":"Dengue vaccine: WHO position paper, September 2018 - recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib15","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/S1473-3099(18)30494-8","article-title":"Deliberations of the strategic advisory group of experts on immunization on the use of CYD-TDV dengue vaccine","volume":"19","author":"Wilder-Smith","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.105728_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.605087","article-title":"Decreased type I interferon production by plasmacytoid dendritic cells contributes to severe dengue","volume":"11","author":"Upasani","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105728_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00281-017-0625-1","article-title":"Immune-mediated cytokine storm and its role in severe dengue","volume":"39","author":"Srikiatkhachorn","year":"2017","journal-title":"Semin Immunopathol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105728_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/omi.2017.0135","article-title":"Clinical proteomics and cytokine profiling for dengue fever disease severity biomarkers","volume":"21","author":"Jadhav","year":"2017","journal-title":"OMICS"},{"key":"10.1016\/j.ebiom.2025.105728_bib22","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.3389\/fmicb.2019.02836","article-title":"Quantitative comparative proteomics reveal biomarkers for dengue disease severity","volume":"10","author":"Han","year":"2019","journal-title":"Front Microbiol"},{"issue":"6365","key":"10.1016\/j.ebiom.2025.105728_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2025.105728_bib24","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7024.1","article-title":"Pathogenesis of dengue: dawn of a new era","volume":"4","author":"Halstead","year":"2015","journal-title":"F1000Res"},{"issue":"749","key":"10.1016\/j.ebiom.2025.105728_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn2199","article-title":"Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1","volume":"16","author":"Zambrana","year":"2024","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105728_bib26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41591-024-02798-x","article-title":"Severe disease during both primary and secondary dengue virus infections in pediatric populations","volume":"30","author":"Aggarwal","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105728_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiaa351","article-title":"A phase 1, open-label assessment of a dengue virus-1 live virus human challenge strain","volume":"223","author":"Endy","year":"2021","journal-title":"J Infect Dis"},{"issue":"668","key":"10.1016\/j.ebiom.2025.105728_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo5019","article-title":"Evolution of inflammation and immunity in a dengue virus 1 human infection model","volume":"14","author":"Waickman","year":"2022","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105728_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.1987.36.435","article-title":"Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers","volume":"36","author":"McKee","year":"1987","journal-title":"Am J Trop Med Hyg"},{"issue":"1-2","key":"10.1016\/j.ebiom.2025.105728_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-0934(01)00280-4","article-title":"Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences","volume":"95","author":"Houng","year":"2001","journal-title":"J Virol Methods"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105728_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105728_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2334-8-86","article-title":"Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity","volume":"8","author":"Bozza","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105728_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2149\/tmh.2014-09","article-title":"The association of cytokines with severe dengue in children","volume":"42","author":"Mangione","year":"2014","journal-title":"Trop Med Health"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105728_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001887","article-title":"Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF","volume":"6","author":"Kumar","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib35","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/s41467-021-22930-6","article-title":"Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model","volume":"12","author":"Hanley","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105728_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/1079990041689665","article-title":"Induction and regulation of IFNs during viral infections","volume":"24","author":"Malmgaard","year":"2004","journal-title":"J Interferon Cytokine Res"},{"issue":"Pt 8","key":"10.1016\/j.ebiom.2025.105728_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J Cell Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105728_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/vaccines7040145","article-title":"The interplay between dengue virus and the human innate immune system: a game of hide and seek","volume":"7","author":"Tremblay","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4149\/av_2023_110","article-title":"Kinetics of interferon-lambda and receptor expression in response to in vitro respiratory viral infection","volume":"67","author":"Lozhkov","year":"2023","journal-title":"Acta Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105728_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jir.2014.0129","article-title":"Dengue virus control of type I IFN responses: a history of manipulation and control","volume":"35","author":"Castillo Ramirez","year":"2015","journal-title":"J Interferon Cytokine Res"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105728_bib41","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1128\/JVI.79.9.5414-5420.2005","article-title":"Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression","volume":"79","author":"Jones","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105728_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105728_bib43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-019-0182-z","article-title":"Interferon-lambda orchestrates innate and adaptive mucosal immune responses","volume":"19","author":"Ye","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105728_bib44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105728_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009713","article-title":"Identifying protein biomarkers in predicting disease severity of dengue virus infection using immune-related protein microarray","volume":"97","author":"Soe","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ebiom.2025.105728_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijid.2020.01.026","article-title":"Interferon lambda 1 is associated with dengue severity in Thailand","volume":"93","author":"Arayasongsak","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105728_bib47","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/pathogens12111362","article-title":"Viremia and inflammatory cytokines in dengue: interleukin-2 as a biomarker of infection, and interferon-alpha and -gamma as markers of primary versus secondary infection","volume":"12","author":"de Arruda","year":"2023","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105728_bib48","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/340365","article-title":"Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections","volume":"185","author":"Libraty","year":"2002","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105728_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240637","article-title":"Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in approximately 10% of patients","volume":"221","author":"Gervais","year":"2024","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib50","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1093\/infdis\/jiae321","article-title":"Severe West Nile virus and severe acute respiratory syndrome coronavirus 2 infections in a patient with Thymoma and anti-type I interferon antibodies","volume":"231","author":"Barzaghi","year":"2025","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105728_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250164","article-title":"Autoantibodies targeting type I interferons: prevalence, mechanisms of induction, and association with viral disease susceptibility","volume":"53","author":"Hale","year":"2023","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105728_bib52","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105728_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3934\/microbiol.2023015","article-title":"SARS-CoV-2 infection and immune responses","volume":"9","author":"Harne","year":"2023","journal-title":"AIMS Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105728_bib54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2020.07.005","article-title":"Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients","volume":"28","author":"Wang","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105728_bib55","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S2213-2600(21)00384-2","article-title":"Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Kalil","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105728_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105728_bib57","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with Pegylated interferon lambda for Covid-19","volume":"388","author":"Reis","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011041","article-title":"Longitudinal proteomic profiling of the inflammatory response in dengue patients","volume":"17","author":"Garishah","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105728_bib59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.freeradbiomed.2022.11.037","article-title":"Differential expression of interferon inducible protein: guanylate binding protein (GBP1 & GBP2) in severe dengue","volume":"194","author":"Mariappan","year":"2023","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105728_bib60","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1084\/jem.20182031","article-title":"Interferon-induced guanylate-binding proteins: guardians of host defense in health and disease","volume":"216","author":"Tretina","year":"2019","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105728_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079518","article-title":"Protective roles of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in dengue virus infection of human lung epithelial cells","volume":"8","author":"Hsu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105728_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199306","article-title":"Temporal cytokine storm dynamics in dengue infection predicts severity","volume":"341","author":"Bhatt","year":"2024","journal-title":"Virus Res"},{"key":"10.1016\/j.ebiom.2025.105728_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2334-13-341","article-title":"Serum IL-10 as a marker of severe dengue infection","volume":"13","author":"Malavige","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imm.13185","article-title":"T-cells producing multiple combinations of IFNgamma, TNF and IL10 are associated with mild forms of dengue infection","volume":"160","author":"Goncalves Pereira","year":"2020","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105728_bib65","first-page":"202","article-title":"Role of TNF alpha, IL-6 and CXCL10 in Dengue disease severity","volume":"10","author":"Masood","year":"2018","journal-title":"Iran J Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105728_bib66","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1086\/517807","article-title":"Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever","volume":"177","author":"Bethell","year":"1998","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105728_bib67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-0039.2004.00304.x","article-title":"TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients","volume":"64","author":"Fernandez-Mestre","year":"2004","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105728_bib68","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/cmi.2015.52","article-title":"Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105728_bib69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0952-7915(03)00107-9","article-title":"Granzyme B: pro-apoptotic, antiviral and antitumor functions","volume":"15","author":"Trapani","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ebiom.2025.105728_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107241","article-title":"The immune checkpoint receptor LAG3: structure, function, and target for cancer immunotherapy","volume":"300","author":"Mariuzza","year":"2024","journal-title":"J Biol Chem"},{"issue":"5-6","key":"10.1016\/j.ebiom.2025.105728_bib71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.18632\/genesandcancer.180","article-title":"The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy","volume":"9","author":"Long","year":"2018","journal-title":"Genes Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105728_bib72","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1002\/jcb.26645","article-title":"T cell exhaustion in cancer: mechanisms and clinical implications","volume":"119","author":"Wang","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ebiom.2025.105728_bib73","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479-480","author":"Kahan","year":"2015","journal-title":"Virology"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105728_bib74","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1128\/JVI.01424-16","article-title":"Characterization of human CD8 T cell responses in dengue virus-infected patients from India","volume":"90","author":"Chandele","year":"2016","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105728_bib75","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/jit436","article-title":"A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand","volume":"209","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105728_bib76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12879-025-10486-5","article-title":"Leukopenia and thrombocytopenia in dengue patients presenting in the emergency department of a tertiary center in Nepal: a cross-sectional study","volume":"25","author":"Thapa","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"21","key":"10.1016\/j.ebiom.2025.105728_bib77","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3390\/diagnostics13213365","article-title":"Genetic association studies of MICB and PLCE1 with severity of dengue in Indonesian and Taiwanese populations","volume":"13","author":"Faridah","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ebiom.2025.105728_bib78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2350-15-58","article-title":"A replication study confirms the association of GWAS-identified SNPs at MICB and PLCE1 in Thai patients with dengue shock syndrome","volume":"15","author":"Dang","year":"2014","journal-title":"BMC Med Genet"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105728_bib79","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/ng.960","article-title":"Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1","volume":"43","author":"Khor","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105728_bib80","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.leu.2404862","article-title":"Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells","volume":"21","author":"Kato","year":"2007","journal-title":"Leukemia"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:22Z","timestamp":1762618582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":73,"alternative-id":["S2352396425001720"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105728","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105728"}}